Rnd3/RhoE induces tight junction formation in mammary epithelial tumor cells

Nicola M Rubenstein1, James F Chan, Joseph Y Kim

  • 1Department of Molecular and Cell Biology and The Cancer Research Laboratory, University of California, Berkeley, CA 94720-3200, USA.

Insights

Rnd3/RhoE, a RhoA antagonist, promotes mammary epithelial cell junction formation and sealing. This discovery reveals a new regulator for apical junction complex assembly and tight junction function.

Area of Science:

  • Cell biology
  • Molecular biology
  • Biochemistry

Background:

  • Glucocorticoid hormones regulate mammary epithelial cell junctions via signal transduction.
  • Dexamethasone-induced apical junction formation requires RhoA downregulation.

Purpose of the Study:

  • To identify key regulators of apical junction dynamics.
  • To elucidate the role of Rnd3/RhoE in mammary epithelial cell junction formation.

Main Methods:

  • Exogenous expression of Rnd3/RhoE in Con8 cells.
  • Immunofluorescence microscopy to assess protein localization (beta-catenin, ZO-1, actin).
  • Assessment of tight junction sealing.
  • Analysis of RhoA's disruptive effects and Rnd3/RhoE rescue.

Main Results:

  • Rnd3/RhoE expression induced beta-catenin and ZO-1 localization to cell-cell contacts.
  • Rnd3/RhoE promoted highly sealed tight junctions independently of glucocorticoids.
  • Rnd3/RhoE antagonized RhoA, rescuing junctional organization defects.

Conclusions:

  • Rnd3/RhoE is a novel regulator of apical junction complex assembly.
  • Rnd3/RhoE plays a critical role in tight junction sealing.
  • Rnd3/RhoE acts as a RhoA antagonist in regulating junction dynamics.